Experimental model in vivo for quantitative assessment of bone resorption inhibition.
Quantitative assessment of bone resorption inhibition in vivo is not easily accomplished; methods relying on a count of osteoclasts are questionable, and histomorphometric evaluation of the bone mass presents several technical problems as well. The authors developed a simple method to measure the inhibition of bone resorption by study of the proximal tibial metaphysis of growing rats: the height of the perichondrial bone ring was taken as an index of the balance between osteoblastic and osteoclastic activity because any agent that inhibits osteoclasts (without interference with osteoblasts) produces an increase in the height of this anatomical structure. Since the ring is well demarcated by surrounding tissues, its height can be measured with accuracy and used for quantitative assessment of bone resorption inhibition. This model was tested with salmon calcitonin, and it provides evidence in vivo that this hormone inhibits osteoclastic bone resorption.
Pazzaglia
U E
UE
Clinica Ortopedica e Traumatologica, II Facoltà di Medicina e Chirurgia, Università di Pavia, Ospedale F. Del Ponte, Varese, Italy.
Zatti
G
G
Di Nucci
A
A
Coci
A
A
Cherubino
P
P
D000818:Animals; D001862:Bone Resorption; D002116:Calcitonin / Q000494:pharmacology; D010010:Osteoclasts / Q000648:ultrastructure; D051381:Rats; D017207:Rats, Sprague-Dawley; D012474:Salmon; D013977:Tibia / Q000166:cytology / Q000187:drug effects* / Q000254:growth & development
D002116:Calcitonin